News

Valneva SE (NASDAQ: VALN) shares closed up 26% at $7.13 after the EMA validated the marketing application for PF-07307405, a Lyme disease vaccine candidate partnered with Pfizer.

Daré Bioscience, Inc. (NASDAQ: DARE) shares closed down 32% at $0.93 after the company announced the pricing of a $6.0 million registered direct offering at $1.37 per share, including concurrent Series A and B warrants.

NeOnc Technologies (NASDAQ: NTHI) shares closed up 31% at $4.22 after the company hosted an investor call highlighting favorable Phase 2a NEO100-01 results for recurrent IDH1-mutant high-grade glioma.

Business activity grew strongly in New York State in August, according to firms responding to the Empire State Manufacturing Survey conducted by the Federal Reserve Bank of New York. The headline general business conditions index rose five points to 20.6, its highest reading in …

Freenome (NASDAQ:FRNM) shares rose 3.37% in pre-market trading to $11.95, up from a prior close of $11.56, after the U.S. Food and Drug Administration granted Breakthrough Device Designation to SimpleScreen Lung, the company's investigational blood-based lung cancer screening test. The designation applies to the …

Hemab Therapeutics (NASDAQ:COAG) shares rose 5.57% in pre-market trading to $58.00, extending a multi-week rally to fresh 52-week highs following a string of bullish analyst actions after the company's second quarterEarningsreport and pipeline updates. Multiple research firms raised price targets and reiterated Buy ratings …

Ocular Therapeutix (NASDAQ:OCUL) shares rose 15.04% in pre-market trading to $11.55, up from a prior close of $10.04. No company-specific announcement dated today was identified as the driver of the move, and the most recent trading commentary available describes a quiet, largely unchanged session …